Yeow Tee Goh


Affiliation: Singapore General Hospital
Country: Singapore


  1. Gupta N, Goh Y, Min C, Lee J, Kim K, Wong R, et al. Pharmacokinetics and safety of ixazomib plus lenalidomide-dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 study. J Hematol Oncol. 2015;8:103 pubmed publisher
    ..0 mg. Consequently, East Asian patients enrolled in phase 3 studies are receiving the same ixazomib dose as patients in other regions. This study is registered at NCT01645930. ..
  2. Tan D, Phipps C, Hwang W, Tan S, Yeap C, Chan Y, et al. Panobinostat in combination with bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma: an open-label, multicentre phase 2 trial. Lancet Haematol. 2015;2:e326-33 pubmed publisher
    ..Novartis Pharmaceuticals, Janssen Pharmaceuticals, and Singhealth Foundation. ..